Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Delavirdine:MCnc:Pt:Ser/Plas:Qn

Known as: Délavirdine:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif, ?????:????:????:??/??:??, Delavirdine:Massa concentratie:Moment:Serum of plasma:Kwantitatief 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
OBJECTIVES To investigate different dose combinations of amprenavir and delavirdine in order to assess an optimal dose suitable… Expand
  • figure 1
  • figure 2
2000
2000
Delavirdine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, is metabolized primarily through desalkylation catalyzed… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
1999
1999
Delavirdine is an antiretroviral drug now being used as part of combination antiretroviral therapy for the management of human… Expand
1998
1998
Four non-nucleoside reverse transcriptase (RT) inhibitors, 9-Cl-TIBO [(+)-S-4,5,6,7-tetrahydro-9-chloro-5-methyl-6-(3-methyl-2… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
1997
Highly Cited
1997
  • C. L. Cheng, D E Smith, +7 authors P. Stetson
  • Clinical pharmacology and therapeutics
  • 1997
  • Corpus ID: 34122850
The steady‐state kinetics of delavirdine and desisopropyldelavirdine were evaluated in human immunodeficiency virus‐positive… Expand
1997
1997
Delavirdine mesylate (U-90152T) is a highly specific nonnucleoside reverse transcriptase inhibitor currently under development… Expand
  • figure 2
  • figure 3
  • table 1
  • table 2
  • figure 4
1997
1997
Delavirdine mesylate (U-90152T) is a highly specific nonnucleoside HIV-1 reverse transcriptase inhibitor currently under… Expand
  • table 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
1996
1996
This study was performed to determine delavirdine protein-binding characteristics as well as those of its N-dealkylated… Expand
1996
1996
  • T. Smart
  • GMHC treatment issues : the Gay Men's Health…
  • 1996
  • Corpus ID: 38558703
For the first time, the Food and Drug Administration (FDA) Antiviral Advisory Committee has not been able to recommend approval… Expand